Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Medical Marijuana in New York: The First Upper East Side Doctor to Prescribe Medical Marijuana Overcomes Misconceptions & Helps Ailing Patients
  • USA - English


News provided by

Dr. Thomas O'Brien

Mar 16, 2016, 09:50 ET

Share this article

Share toX

Share this article

Share toX

Upper east side physician Dr. Thomas (Doc Tommy) O'Brien has assisted over 200 patients achieve medical marijuana certification since the law went into effect in early January 2016.
Upper east side physician Dr. Thomas (Doc Tommy) O'Brien has assisted over 200 patients achieve medical marijuana certification since the law went into effect in early January 2016.
Youtube
Youtube

New York, NY (PRWEB) March 16, 2016 -- On January 16, 2016, New York physician Dr. Thomas O’Brien secured certification for his first patient to be prescribed medical marijuana, just after the program launched and the first eight dispensaries in the state opened on January 7. Dr. O’Brien has since assisted over 200 patients achieve certification for medical marijuana in New York in the last 90 days with positive results and feedback from individuals suffering from brain cancer, lung cancer, pancreatic cancer, multiple sclerosis, irritable bowel disease, HIV, ALS and neuropathies.

My primary focus is to alleviate symptoms so my patients may perform daily functions relatively symptom free. For those patients at end of life, my focus is to make them comfortable so that they may have quality of life to spend with their families...

Post this

Dr. O’Brien believes obtaining his physician certification as a medical marijuana doctor with the New York State Department of Health's Medical Marijuana Program was the natural progression in his practice of medicine. O’Brien, who has been in practice for 18 years, is board certified in Integrated Medicine and holds a Masters degree in Clinical Nutrition. He began his career as a family physician and treated patients for Acute Care and Continuous Care. In caring for more severely ill patients, his focus grew to Compassionate Care and Palliative Care. He is one of seven Manhattan doctors with M-MJP certification, with just 28 New York State doctors presently listed on the web site MarijuanaDoctors.com. However, the New York State Department of Health web site notes that as of March 2, 445 physicians have registered and 1,399 patients have been certified for treatment, yet the department still lacks a comprehensive practitioner list to allow prospective patients to find care.

Currently, under New York State’s Medical Marijuana Law (S7923/A6357-E) specific requirements must be met and patients are potentially eligible for medical cannabis if they have been diagnosed with a specific severe, debilitating or life threatening condition accompanied by an associated or complicating condition. By law, those conditions are: cancer, HIV infection or AIDS, amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis, spinal cord injury with spasticity, epilepsy, inflammatory bowel disease, neuropathy, and Huntington's disease. The associated or complicating conditions are cachexia or wasting syndrome, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms.

“My primary focus is to alleviate symptoms so my patients may perform daily functions relatively symptom free,” explains Dr. O’Brien. “For those patients who have exhausted traditional therapies and are at end of life, my focus is to make them comfortable so that they may have quality of life to spend with their families for whatever time remains.”

Placing a strong emphasis on education, Dr. O’Brien spends significant time with each patient so that they thoroughly understand the certification process, doses, and benefits. “Doc Tommy,” as he is known to his patients, creates an open, non-rushed environment where patients and family members can comfortably ask questions and discuss all concerns. “My mission is to educate our community on the benefits of medical marijuana," the doctor explains. In consulting with his patients, O’Brien learned that a significant number of them had self-medicated with street marijuana, already realizing the benefits.

“The legalization of medical marijuana now takes procurement off the streets where the substance contains a much higher ratio of THC, resulting in unwanted psychoactive side effects. It can also be laced with other contaminants. Now I am able to offer seriously ill or end of life patients, a legal, safe, reliable alternative, cultivated in a controlled environment with no added chemicals,” explains O’Brien. The biggest challenge for the doctor has been creating awareness with New York City residents that his services are a viable and effective option to traditional therapies that have failed to provide relief for patients in the past. “The greatest misconception regarding medical marijuana is that people believe patients will walk the streets high,” he notes. Medical marijuana also removes the need to smoke the substance with calculated dosages available in vapor, sublingual and pill forms, depending upon the ailment.

In continuously monitoring patients beginning with their first follow up one month after commencing marijuana therapy, the doctor has seen promising results with many patients living more comfortably than they had in years. He is hopeful that New York State will expand the scope of diagnosis covered by the Compassionate Care Act so that more individuals can benefit from medical marijuana.

Dr. Thomas O’Brien’s office is located at 121 East 60th Street in Manhattan. As with all M-MJP certified practitioners, health insurance does not cover this area of care. Fees vary from physician to physician and Dr. O’Brien’s rates have been reduced to make care more accessible. As a former Captain and Commanding Officer in the New York Guard's, 88th Brigade, 102 Forward Support Medical Detachment, Dr. O’Brien offers further reduced rates to those having served in any branch of the US Armed Forces.

For more information on obtaining patient medical marijuana certification and learning more about the benefits of treatment, individuals with eligible conditions may visit DocTommy.com or call (212) 201-9122.

Kathy Shoob @, Dr. Thomas O'Brien, http://DocTommy.com, +1 (212) 201-9122, [email protected]

Modal title

Upper east side physician Dr. Thomas (Doc Tommy) O'Brien has assisted over 200 patients achieve medical marijuana certification since the law went into effect in early January 2016.
Upper east side physician Dr. Thomas (Doc Tommy) O'Brien has assisted over 200 patients achieve medical marijuana certification since the law went into effect in early January 2016.
Upper east side physician Dr. Thomas (Doc Tommy) O'Brien has assisted over 200 patients achieve medical marijuana certification since the law went into effect in early January 2016.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.